{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:49:27Z","timestamp":1776235767500,"version":"3.50.1"},"reference-count":41,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["AIAAMC"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Parkinson\u2019s disease (PD) is a progressive neurodegenerative disease manifested by core symptoms of loss of motor control and postural instability. Loss of dopaminergic neurons is the cause of PD, thus enhancing dopamine level by pharmacological treatment is one of the key treatment strategies for PD. However, the limitations of current treatment strategies open the possibility of novel drug candidates for the treatment of PD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>To investigate the anti-PD potential of Harmine and Harmaline. We aim to evaluate the therapeutic potential of Harmine and Harmaline by in-silico approaches; molecular docking, pharmacokinetic and Prediction of Activity Spectra for Substances (PASS) analysis were used for evaluating the therapeutic potential of Harmine and Harmaline and standard drug levodopa (L-DOPA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Auto dock vina was used for molecular docking of all three compounds against D2- and D3- dopamine receptors. The pharmacokinetics (PKs) and toxicity profile were predicted by pkCSM, and the pharmacological activity was predicted by PASS analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Molecular docking showed a higher binding affinity of Harmine and Harmaline as compared to L-DOPA, and these results were supported by in-silico pharmacokinetic and toxicity profiling. Moreover, PASS analysis showed anti-PD activity of Harmine and Harmaline.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Harmine and Harmaline exhibit higher binding affinity towards D2- and D3- dopamine receptors compared to L-DOPA, and PKs and toxicity profile support their potential as drug candidates for PD therapy.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871523019999201111192344","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T04:31:53Z","timestamp":1605241913000},"page":"250-263","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["<i>In-silico<\/i>Prediction of the Beta-carboline Alkaloids Harmine and Harmaline as Potent Drug Candidates for the Treatment of Parkinson\u2019s disease"],"prefix":"10.2174","volume":"20","author":[{"given":"Rumpa","family":"Banerjee","sequence":"first","affiliation":[{"name":"Eminent College of Pharmaceutical Technology, Barasat, Kolkata,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research (NIPER), Guwahati,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isha","family":"Gaurav","sequence":"additional","affiliation":[{"name":"Department of Botany, Patna Women\u2019s College, Patna, Bihar,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudha","family":"Thakur","sequence":"additional","affiliation":[{"name":"National Institute for Locomotor Disabilities (Divyangjan), Kolkata,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhimanyu","family":"Thakur","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences &amp; Technology, Birla Institute of Technology, Mesra, Ranchi,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, HIMT College (CCS University Meerut), Uttar Pradesh,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanchari","family":"Karak","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Bharat Technology, Uluberia, Howrah,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeswar","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Bharat Technology, Uluberia, Howrah,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohit","family":"Chhabra","sequence":"additional","affiliation":[{"name":"School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane,Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"de Lau L.M.L.","year":"2006","unstructured":"de Lau L.M.L.; Breteler M.M.B.; Epidemiology of Parkinson\u2019s disease. Lancet Neurol 2006,5(6),525-535","journal-title":"Lancet Neurol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/mds.26510","volume":"31","author":"Marras C.","year":"2016","unstructured":"Marras C.; Chaudhuri K.R.; Nonmotor features of Parkinson\u2019s disease subtypes. Mov Disord 2016,31(8),1095-1102","journal-title":"Mov Disord"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1001\/archneur.63.4.584","volume":"63","author":"Greffard S.","year":"2006","unstructured":"Greffard S.; Verny M.; Bonnet A.M.; Beinis J.Y.; Gallinari C.; Meaume S.; Piette F.; Hauw J.J.; Duyckaerts C.; Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. Arch Neurol 2006,63(4),584-588","journal-title":"Arch Neurol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"100994","DOI":"10.1016\/j.arr.2019.100994","volume":"57","author":"Yang P.","year":"2020","unstructured":"Yang P.; Perlmutter J.S.; Benzinger T.L.S.; Morris J.C.; Xu J.; Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment? Ageing Res Rev 2020,57,100994","journal-title":"Ageing Res Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nature25758","volume":"555","author":"Wang S.","year":"2018","unstructured":"Wang S.; Che T.; Levit A.; Shoichet B.K.; Wacker D.; Roth B.L.; Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone. Nature 2018,555(7695),269-273","journal-title":"Nature"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.neuron.2017.02.029","volume":"93","author":"Howard C.D.","year":"2017","unstructured":"Howard C.D.; Li H.; Geddes C.E.; Jin X.; Dynamic Nigrostriatal Dopamine Biases Action Selection. Neuron 2017,93(6),1436-1450","journal-title":"Neuron"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.tips.2005.05.002","volume":"26","author":"Mercuri N.B.","year":"2005","unstructured":"Mercuri N.B.; Bernardi G.; The \u2018magic\u2019 of L-dopa: why is it the gold standard Parkinson\u2019s disease therapy? Trends Pharmacol Sci 2005,26(7),341-344","journal-title":"Trends Pharmacol Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/mds.26125","volume":"30","author":"Aquino C.C.","year":"2015","unstructured":"Aquino C.C.; Fox S.H.; Clinical spectrum of levodopa-induced complications. Mov Disord 2015,30(1),80-89","journal-title":"Mov Disord"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S1471-1931(00)00031-8","volume":"23","author":"Obeso J.A.","year":"2000","unstructured":"Obeso J.A.; Olanow C.W.; Nutt J.G.; Givup G.; Levodopa motor complications in Parkinson\u2019s disease. Trends Neurosci 2000,23(10)(Suppl.),S2-S7","journal-title":"Trends Neurosci"},{"key":"ref=10","first-page":"415","author":"de la Fuente-Fern&#xE1;ndez R.","year":"2006","unstructured":"de la Fuente-Fern&#xE1;ndez R.; Lidstone S.; Stoessl A.J.; Placebo effect and dopamine release. J Neural Transm Suppl 2006(70),415-418","journal-title":"J Neural Transm Suppl"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000119538","volume":"34","author":"Ogawa N.","year":"1994","unstructured":"Ogawa N.; Levodopa and dopamine agonists in the treatment of Parkinson\u2019s disease: Advantages and disadvantages. Eur Neurol 1994,34(Suppl. 3),20-28","journal-title":"Eur Neurol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fphar.2010.00005","volume":"1","author":"Su D-F.","year":"2010","unstructured":"Su D-F.; Defining pharmacology of natural products in the 21st century - challenge on multiple fronts. Front Pharmacol 2010,1,5","journal-title":"Front Pharmacol"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.82860","author":"Amit Koparde A.","year":"2019","unstructured":"Amit Koparde A.; Chandrashekar Doijad R.; Shripal Magdum C.; Natural Products in Drug Discovery. Pharmacognosy - Medicinal Plants 2019","journal-title":"Pharmacognosy - Medicinal Plants"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fphar.2013.00177","volume":"4","author":"Ekor M.","year":"2014","unstructured":"Ekor M.; The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014,4,177","journal-title":"Front Pharmacol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/02791072.2005.10399795","volume":"37","author":"Callaway J.C.","year":"2005","unstructured":"Callaway J.C.; Brito G.S.; Neves E.S.; Phytochemical analyses of Banisteriopsis caapi and Psychotria viridis. J Psychoactive Drugs 2005,37(2),145-150","journal-title":"J Psychoactive Drugs"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"e0145840","DOI":"10.1371\/journal.pone.0145840","volume":"10","author":"Favaro V.M.","year":"2015","unstructured":"Favaro V.M.; Yonamine M.; Soares J.C.K.; Oliveira M.G.M.; Effects of long-term ayahuasca administration on memory and anxiety in rats. PLoS One 2015,10(12),e0145840","journal-title":"PLoS One"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/02791072.2002.10399963","volume":"34","author":"Rodd R.","year":"2002","unstructured":"Rodd R.; Snuff synergy: preparation, use and pharmacology of yopo and Banisteriopsis caapi among the Piaroa of southern Venezuela. J Psychoactive Drugs 2002,34(3),273-279","journal-title":"J Psychoactive Drugs"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jep.2010.02.013","volume":"128","author":"Wang Y.H.","year":"2010","unstructured":"Wang Y.H.; Samoylenko V.; Tekwani B.L.; Khan I.A.; Miller L.S.; Chaurasiya N.D.; Rahman M.M.; Tripathi L.M.; Khan S.I.; Joshi V.C.; Wigger F.T.; Muhammad I.; Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson\u2019s disease. J Ethnopharmacol 2010,128(3),662-671","journal-title":"J Ethnopharmacol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/mdc3.12242","volume":"3","author":"Djamshidian A.","year":"2015","unstructured":"Djamshidian A.; Bernschneider-Reif S.; Poewe W.; Lees A.J.; Banisteriopsis caapi, a Forgotten Potential Therapy for Parkinson\u2019s Disease? Mov Disord Clin Pract (Hoboken) 2015,3(1),19-26","journal-title":"Mov Disord Clin Pract (Hoboken)"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jep.2009.10.030","volume":"127","author":"Samoylenko V.","year":"2010","unstructured":"Samoylenko V.; Rahman M.M.; Tekwani B.L.; Tripathi L.M.; Wang Y-H.; Khan S.I.; Khan I.A.; Miller L.S.; Joshi V.C.; Muhammad I.; Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson\u2019s disease. J Ethnopharmacol 2010,127(2),357-367","journal-title":"J Ethnopharmacol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jep.2007.04.012","volume":"112","author":"Santos R.G.","year":"2007","unstructured":"Santos R.G.; Landeira-Fernandez J.; Strassman R.J.; Motta V.; Cruz A.P.M.; Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. J Ethnopharmacol 2007,112(3),507-513","journal-title":"J Ethnopharmacol"},{"key":"ref=22","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.72898","author":"Phillips M.A.","year":"2018","unstructured":"Phillips M.A.; Stewart M.A.; Woodling D.L.; Xie Z-R.; Molecular Docking 2018","journal-title":"Molecular Docking"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0959-440X(96)80061-3","volume":"6","author":"Lengauer T.","year":"1996","unstructured":"Lengauer T.; Rarey M.; Computational methods for biomolecular docking. Curr Opin Struct Biol 1996,6(3),402-406","journal-title":"Curr Opin Struct Biol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nrd1549","volume":"3","author":"Kitchen D.B.","year":"2004","unstructured":"Kitchen D.B.; Decornez H.; Furr J.R.; Bajorath J.; Docking and scoring in virtual screening for drug discovery: Methods and applications. Nat Rev Drug Discov 2004,3(11),935-949","journal-title":"Nat Rev Drug Discov"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"Trott O.","year":"2010","unstructured":"Trott O.; Olson A.J.; AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010,31(2),455-461","journal-title":"J Comput Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2174\/1389201021666200702152000","volume":"21","author":"Gaurav I.","year":"2020","unstructured":"Gaurav I.; Singh T.; Thakur A.; Kumar G.; Rathee P.; Kumari P.; Sweta K.; Synthesis, in-vitro and in-silico evaluation of Silver Nanoparticles with Root Extract of Withania somnifera for antibacterial activity via binding of penicillin binding protein-4. Curr Pharm Biotechnol 2020,21(15),1674-1687","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"Morris G.M.","year":"2009","unstructured":"Morris G.M.; Huey R.; Lindstrom W.; Sanner M.F.; Belew R.K.; Goodsell D.S.; Olson A.J.; AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 2009,30(16),2785-2791","journal-title":"J Comput Chem"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-4-17","volume":"4","author":"Hanwell MD","year":"2012","unstructured":"Hanwell MD; Curtis DE; Lonie DC; Vandermeersch T; Zurek E; Hutchison GR; Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. J Cheminformatics 2012,4,1-17","journal-title":"J Cheminformatics"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"Pettersen E.F.","year":"2004","unstructured":"Pettersen E.F.; Goddard T.D.; Huang C.C.; Couch G.S.; Greenblatt D.M.; Meng E.C.; Ferrin T.E.; UCSF Chimera-A visualization system for exploratory research and analysis. J Comput Chem 2004,25(13),1605-1612","journal-title":"J Comput Chem"},{"key":"ref=30","author":"Schr&#xF6;dinger LLC","year":"2015","unstructured":"Schr&#xF6;dinger LLC; The PyMOL molecular graphics system. Version 18 2015","journal-title":"Version 18"},{"key":"ref=31","author":"Biovia DSJSDDS","year":"2017","unstructured":"Biovia DSJSDDS; Discovery studio modeling environment 2017","journal-title":"Discovery studio modeling environment"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","volume":"46","author":"Banerjee P.","year":"2018","unstructured":"Banerjee P.; Eckert A.O.; Schrey A.K.; Preissner R.; ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Res 2018,46(W1),W257-W263","journal-title":"Nucleic Acids Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"Pires D.E.V.","year":"2015","unstructured":"Pires D.E.V.; Blundell T.L.; Ascher D.B.; pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 2015,58(9),4066-4072","journal-title":"J Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"Daina A.","year":"2017","unstructured":"Daina A.; Michielin O.; Zoete V.; SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017,7,42717","journal-title":"Sci Rep"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2174\/1871523018666190405114524","volume":"19","author":"Venugopal V.C.","year":"2020","unstructured":"Venugopal V.C.; Thakur A.; Chennabasappa L.K.; Mishra G.; Singh K.; Rathee P.; Ranjan A.; Phycocyanin Extracted from Oscillatoria minima Shows Antimicrobial, Algicidal, and Antiradical Activities: In silico and in vitro analysis. Antiinflamm Antiallergy Agents Med Chem 2020,19(3),240-253","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/cmdc.201600182","volume":"11","author":"Daina A.","year":"2016","unstructured":"Daina A.; Zoete V.; A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 2016,11(11),1117-1121","journal-title":"ChemMedChem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4103\/0976-500X.77119","volume":"2","author":"Parasuraman S.","year":"2011","unstructured":"Parasuraman S.; Prediction of activity spectra for substances. J Pharmacol Pharmacother 2011,2(1),52-53","journal-title":"J Pharmacol Pharmacother"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1038\/s41598-018-22362-1","volume":"8","author":"Singh S.P.","year":"2018","unstructured":"Singh S.P.; Nongalleima K.; Singh N.I.; Doley P.; Singh C.B.; Singh T.R.; Sahoo D.; Zerumbone reduces proliferation of HCT116 colon cancer cells by inhibition of TNF-alpha. Sci Rep 2018,8(1),4090","journal-title":"Sci Rep"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1093\/bioinformatics\/btt540","volume":"29","author":"Gfeller D.","year":"2013","unstructured":"Gfeller D.; Michielin O.; Zoete V.; Shaping the interaction landscape of bioactive molecules. Bioinformatics 2013,29(23),3073-3079","journal-title":"Bioinformatics"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1111\/j.1471-4159.1983.tb08123.x","volume":"40","author":"Fowler C.J.","year":"1983","unstructured":"Fowler C.J.; Benedetti M.S.; The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone. J Neurochem 1983,40(6),1534-1541","journal-title":"J Neurochem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.neuron.2014.06.034","volume":"83","author":"Madabhushi R.","year":"2014","unstructured":"Madabhushi R.; Pan L.; Tsai L-H.; DNA damage and its links to neurodegeneration. Neuron 2014,83(2),266-282","journal-title":"Neuron"}],"container-title":["Anti-Inflammatory &amp; Anti-Allergy Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/187867","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/187867\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/187867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T21:19:03Z","timestamp":1698355143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/187867\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871523019999201111192344","relation":{},"ISSN":["1871-5230"],"issn-type":[{"value":"1871-5230","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-07-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}